Page last updated: 2024-10-22

amantadine and Atrophy

amantadine has been researched along with Atrophy in 5 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
"Treatment with amantadine and therapy with hyperimmunoglobulins seem to be useful."5.32[Bilateral influenza-triggered panuveitis and subsequent therapy with amantadine and hyperimmunoglobulins]. ( Cinatl, I; Gümbel, HO; Hattenbach, LO; Lipke, KJ; Schäfer, HG, 2004)
"Fatigue is the most common and debilitating symptom in multiple sclerosis (MS) and is believed to be distinctly different from fatigue seen in other chronic conditions."2.48Fatigue in multiple sclerosis - a brief review. ( Constantinescu, CS; Gran, B; Induruwa, I, 2012)
"Treatment with amantadine and therapy with hyperimmunoglobulins seem to be useful."1.32[Bilateral influenza-triggered panuveitis and subsequent therapy with amantadine and hyperimmunoglobulins]. ( Cinatl, I; Gümbel, HO; Hattenbach, LO; Lipke, KJ; Schäfer, HG, 2004)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ene-Stroescu, V1
Nguyen, T1
Waiblinger, BE1
Induruwa, I1
Constantinescu, CS1
Gran, B1
Gümbel, HO1
Lipke, KJ1
Schäfer, HG1
Cinatl, I1
Hattenbach, LO1
Goetz, CG1
Tanner, CM1
Klawans, HL1
Harvey, NS1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Observational Study of the Effect of Ozanimod on Fatigue in Multiple Sclerosis Patients[NCT05319093]40 participants (Anticipated)Observational2022-04-30Not yet recruiting
Self-Management Program Based on Physical Exercises for People With Multiple Sclerosis With Mild Neurological Impairment: A Randomized Controlled Trial[NCT02607020]100 participants (Anticipated)Interventional2015-12-31Recruiting
A PILOT STUDY OF INTRAVENOUS, SUBANESTHETIC DOSE OF KETAMINE VS PLACEBO, A CROSSOVER DESIGN, FOR MULTIPLE SCLEROSIS RELATED FATIGUE[NCT06064162]Early Phase 120 participants (Anticipated)Interventional2023-10-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for amantadine and Atrophy

ArticleYear
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Fatigue in multiple sclerosis - a brief review.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Amantadine; Atrophy; Benzhydryl Compounds; Brain; Clinical Trials as Topic; Cognitive Behavioral The

2012
Psychiatric disorders in parkinsonism: 2. Organic cerebral states and drug reactions.
    Psychosomatics, 1986, Volume: 27, Issue:3

    Topics: Amantadine; Antiparkinson Agents; Atrophy; Brain; Bromocriptine; Cognition; Dementia; Dreams; Drug I

1986

Other Studies

3 other studies available for amantadine and Atrophy

ArticleYear
Successful treatment of catatonia in a young man with schizophrenia and progressive diffuse cerebral atrophy.
    The Journal of neuropsychiatry and clinical neurosciences, 2014,Winter, Volume: 26, Issue:1

    Topics: Adolescent; Amantadine; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Atrophy; Catato

2014
[Bilateral influenza-triggered panuveitis and subsequent therapy with amantadine and hyperimmunoglobulins].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2004, Volume: 101, Issue:7

    Topics: Adult; Amantadine; Antiviral Agents; Atrophy; Drug Therapy, Combination; Female; Follow-Up Studies;

2004
The pharmacology of olivopontocerebellar atrophy.
    Advances in neurology, 1984, Volume: 41

    Topics: Adult; Amantadine; Atrophy; Baclofen; Brain Diseases; Carbidopa; Cerebellar Ataxia; Female; Humans;

1984